Therapeutic superiority and safety of combined hydroxyurea with recombinant human erythropoietin over hydroxyurea in b-thalassemia intermedia patients

Authors
Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: 20fee5ebeb52d1eeb3d8d998dfd26a35a6cc70e2
First added on: Feb 05, 2025